Paul Stamets on health: what the evidence says · JRE #1385

FACT CHECK // JRE #1385 // EXHIBIT LOG
EPISODE AIRED NOV 1, 2019 · THE JOE ROGAN EXPERIENCE
CLAIM CMRCOVR4STATUS: PUBLISHED
SUBJECT: HEALTH
Timestamp35:47
Aired
RulingNeeds Context

Not a true/false call. Every claim is logged with its sources; read the exhibits below.

// THE CLAIM · ON TAPE
there's two clinical studies out of Japan with mild cognitive decline and dementia showing very positive results taking two to four grams of lion's mane per day, the mycelium
Paul Stamets@ 35:47
Watch on YouTubeJUMP TO 35:47

What the evidence says 01 / RECORD

The claim traces to a single small Japanese trial, Mori et al. (2009, Phytotherapy Research), a 16-week double-blind, placebo-controlled study of 30 adults aged 50-80 with diagnosed mild cognitive impairment (not dementia), who took roughly 3 grams per day of dried Hericium erinaceus fruiting-body powder (not mycelium extract). That trial found modestly improved scores on a dementia screening scale during treatment, but scores declined again within four weeks after supplementation stopped, and the sample size was too small to draw firm conclusions. No second published Japanese clinical trial on lion's mane and dementia or cognitive decline could be identified; a separate, larger erinacine-A mycelium trial reporting cognitive benefit in patients with mild Alzheimer's disease was conducted in Taiwan, not Japan. A 2025 systematic review of Hericium erinaceus clinical research concluded that the supplement "shows limited effectiveness in clinical trials" for cognitive outcomes, with most studies reporting only modest, short-term improvement rather than robust or lasting benefit. Current evidence therefore does not support the claim of two positive Japanese clinical studies on dementia, and the one relevant trial that does exist showed a smaller, more transient effect, using a different mushroom preparation (fruiting body, not mycelium), than implied.

/// factcheckjoerogan.com